Y
Yuko M. Komesu
Researcher at University of New Mexico
Publications - 75
Citations - 2785
Yuko M. Komesu is an academic researcher from University of New Mexico. The author has contributed to research in topics: Urinary incontinence & Medicine. The author has an hindex of 20, co-authored 64 publications receiving 2115 citations. Previous affiliations of Yuko M. Komesu include Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
A Baseline for the Multivariate Comparison of Resting-State Networks
Elena A. Allen,Erik B. Erhardt,Eswar Damaraju,William Gruner,William Gruner,Judith M. Segall,Judith M. Segall,Rogers F. Silva,Rogers F. Silva,Martin Havlicek,Martin Havlicek,Srinivas Rachakonda,Jill Fries,Ravi Kalyanam,Ravi Kalyanam,Andrew M. Michael,Arvind Caprihan,Jessica A. Turner,Jessica A. Turner,Tom Eichele,Steven Adelsheim,Angela D. Bryan,Angela D. Bryan,Juan R. Bustillo,Vincent P. Clark,Vincent P. Clark,Sarah W. Feldstein Ewing,Francesca M. Filbey,Francesca M. Filbey,Corey C. Ford,Kent E. Hutchison,Kent E. Hutchison,Rex E. Jung,Rex E. Jung,Kent A. Kiehl,Kent A. Kiehl,Piyadasa W. Kodituwakku,Yuko M. Komesu,Andrew R. Mayer,Andrew R. Mayer,Godfrey D. Pearlson,John P. Phillips,John P. Phillips,Joseph Sadek,Michael Stevens,Ursina Teuscher,Ursina Teuscher,Robert J. Thoma,Vince D. Calhoun +48 more
TL;DR: A multivariate analytic approach that optimizes sensitivity and reduces unnecessary testing is introduced and is demonstrated by identifying the effects of age and gender on the resting-state networks of 603 healthy adolescents and adults.
Journal ArticleDOI
OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
Cindy L. Amundsen,Holly E. Richter,Shawn A. Menefee,Yuko M. Komesu,Lily A. Arya,W. Thomas Gregory,Deborah L. Myers,Halina M. Zyczynski,Sandip P. Vasavada,Tracy L. Nolen,Dennis Wallace,Susan Meikle +11 more
TL;DR: Among women with refractory urgency urinary incontinence, treatment with onabotulinumtoxinA compared with sacral neuromodulation resulted in a small daily improvement in episodes that although statistically significant is of uncertain clinical importance.
Journal ArticleDOI
Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
Cindy L. Amundsen,Yuko M. Komesu,Christopher Chermansky,W. Thomas Gregory,Deborah L. Myers,Emily Faley Honeycutt,Sandip P. Vasavada,John N. Nguyen,Tracey Wilson,Heidi S. Harvie,Dennis Wallace +10 more
TL;DR: A large group of US women with severe urgency urinary incontinence who received sacral neuromodulation or onabotulinumtoxinA (Botox A) therapy during a 2-yr period found that both therapies had similar success in reducing UUI symptoms, and adverse events were low.
Journal ArticleDOI
Posterior repair and sexual function
TL;DR: Although the incidence of dyspareunia differed between PR and no PR groups, overall improvement in sexual function was reflected in improved total PISQ scores that occurred irrespective of PR performance.
Journal ArticleDOI
Pelvic floor symptom changes in pessary users
Yuko M. Komesu,Rebecca G. Rogers,Martha A. Rode,Ellen Craig,Katey A. Gallegos,Angela Montoya,Carrie D. Swartz +6 more
TL;DR: PFDI-20 scores improved most in women continuing pessaries, and most effectively treated prolapse symptoms, which best predicted continued pessary use.